UDG Healthcare Public Limited Co. Notice of Interim Results (1320W)
25 April 2016 - 4:01PM
UK Regulatory
TIDMUDG
RNS Number : 1320W
UDG Healthcare Public Limited Co.
25 April 2016
25 April 2016
UDG Healthcare plc
Notice of Interim Results
UDG Healthcare plc ("the Company"), a leading international
healthcare services provider, will issue its interim results for
the half year ended 31 March 2016 at 07:00am (BST) on Thursday 19
May 2016.
The Company will be hosting an analyst and investor presentation
at the London Stock Exchange at 09:00am (BST) on Thursday 19 May
2016. Analysts and investors wishing to attend are asked to contact
Powerscourt on the details below. The presentation will also be
available via live audio webcast and conference call, the details
of which are below.
Audio webcast:
http://edge.media-server.com/m/p/3w8qtbpi
Conference call dial-in details:
UK + 44-203-427-1907
-------------------------- ------------------
Ireland + 353-1-246-5601
-------------------------- ------------------
United States of America + 1-212-444-0412
-------------------------- ------------------
Participant Code 9775904
-------------------------- ------------------
For further information, please contact:
UDG Healthcare plc
Keith Byrne
Head of Investor Relations
and Strategy
Tel: + 353-1-463-7722
Powerscourt
Lisa Kavanagh / Jack Hickey
Tel: +44-207-250-1446
udghealthcare@powerscourt-group.com
About UDG Healthcare plc:
UDG Healthcare plc (LON: UDG) is a leading international
provider of services to the healthcare industry, employing over
7,000 employees at operations across 19 countries including the US,
UK, Ireland and Germany.
UDG Healthcare plc operates across three divisions: Ashfield
Commercial & Medical Services, Sharp Packaging Services and
Supply Chain Services.
Ashfield Commercial & Medical Services is a global leader in
the provision of sales, marketing and healthcare communications
services to pharmaceutical companies. It focuses on supporting
healthcare professionals and patients at all stages of the product
life cycle enabling improved compliance and clinical outcomes. The
division provides sales teams, healthcare communications,
telesales, nurse educators, medical information, pharmacovigilance,
regulatory and event management services to over 300 healthcare
companies in 18 countries.
Sharp Packaging Services is a global leader in contract
packaging and clinical trial packaging services for the
pharmaceutical and biotechnology industries, operating from state
of the art facilities across the US and Europe. Sharp is also a
world leader in 'Track and Trace' serialisation services, which
will require all prescription drugs to have a unique serial code
for authentication and traceability.
Supply Chain Services consists of Aquilant, a leading provider
of outsourced sales, marketing, distribution and engineering
services to the medical and scientific sectors in the UK, Ireland
and the Netherlands.
The company is listed on the London Stock Exchange and is a
constituent of the FTSE 250.
For more information please go to: www.udghealthcare.com
This information is provided by RNS
The company news service from the London Stock Exchange
END
NORSESFMEFMSEFL
(END) Dow Jones Newswires
April 25, 2016 02:01 ET (06:01 GMT)
Udg Healthcare Public (LSE:UDG)
Historical Stock Chart
From Apr 2024 to May 2024
Udg Healthcare Public (LSE:UDG)
Historical Stock Chart
From May 2023 to May 2024